Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Intern Med ; 50(18): 1963-7, 2011.
Article in English | MEDLINE | ID: mdl-21921377

ABSTRACT

A young woman who was experiencing repeated convulsions was admitted. The patient's brain magnetic resonance image revealed reversible posterior leukoencephalopathy. Blood pressure fluctuated at times to more than 200 mmHg, and the measurement of the right and left upper arms differed by approximately 70 mmHg. Enhanced computed tomography revealed stenotic lesions of some arteries including the left renal artery. Such findings led to an initial diagnosis of Takayasu arteritis and hypertensive encephalopathy caused by renovascular hypertension. A percutaneous transluminal renal angioplasty was successfully performed. The patient's blood pressure returned to normal value without the use of antihypertensive drugs.


Subject(s)
Hypertension, Renovascular/complications , Hypertensive Encephalopathy/etiology , Renal Artery Obstruction/complications , Takayasu Arteritis/etiology , Angioplasty , Comorbidity , Female , Humans , Hypertension, Renovascular/therapy , Hypertensive Encephalopathy/diagnostic imaging , Hypertensive Encephalopathy/pathology , Magnetic Resonance Imaging , Renal Artery Obstruction/therapy , Takayasu Arteritis/diagnostic imaging , Takayasu Arteritis/pathology , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
2.
Ann Vasc Dis ; 4(3): 256-9, 2011.
Article in English | MEDLINE | ID: mdl-23555464

ABSTRACT

A young male suffering from renovascular hypertension was admitted. His initial arteriogram highlighted a focal stenosis of the right renal artery. His intravascular ultrasound (IVUS) revealed increasing medial layer thickness accompanied by a mixture of both high and low echoic materials in this layer. There was also mild thickening of the intimal layer. The diagnosis of medial fibroplasia and intimal fibromuscular dysplasia (FMD) was made. Balloon angioplasty decreased the volume of dysplastic tissue. The IVUS images facilitated both the initial diagnosis of focal renal arterial stenosis and the evaluation of the mechanism of dilatation by angioplasty.

3.
Circ J ; 74(3): 523-30, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20057160

ABSTRACT

BACKGROUND: Lipocalin-2/neutrophil gelatinase-B associated lipocalin (Lcn2/NGAL) is involved in the transport of iron and seems to play an important role in inflammation. A recent study has reported that it is also expressed in the failing heart and may be a biomarker not only for renal failure but also for heart failure. Because Lcn2/NGAL is thought to be induced by interleukin-1, it might be strongly induced in the presence of myocarditis. METHODS AND RESULTS: This study investigated the expression of Lcn2/NGAL in rat experimental autoimmune myocarditis (EAM) and in human myocarditis. In EAM hearts, the expression of Lcn2/NGAL was markedly increased (>100-fold at an early stage), and in human myocarditis it was also highly expressed compared with non-inflammatory failing hearts. Lcn2/NGAL expressing cells in hearts with EAM and human myocarditis were identified as cardiomyocytes, vascular wall cells, fibroblasts and neutrophils. Lcn2/NGAL in EAM rats was also expressed in the liver. Plasma Lcn2/NGAL levels abruptly increased at an early stage of EAM, and high levels were initially sustained during the inflammatory stage, then decreased with recovery. In contrast, levels of B-type natriuretic peptide increased only slowly as the disease progressed. CONCLUSIONS: Cardiomyocytes, vascular wall cells and fibroblasts in myocarditis strongly express Lcn2/NGAL via proinflammatory cytokines.


Subject(s)
Acute-Phase Proteins/genetics , Autoimmune Diseases/physiopathology , Heart Failure/physiopathology , Lipocalins/genetics , Myocarditis/physiopathology , Proto-Oncogene Proteins/genetics , Acute-Phase Proteins/metabolism , Aged , Animals , Autoimmune Diseases/immunology , Disease Models, Animal , Female , Fibroblasts/physiology , Gene Expression/physiology , Heart Failure/immunology , Humans , Immunization , Interleukin-1beta/blood , Interleukin-1beta/genetics , Lipocalin-2 , Lipocalins/blood , Lipocalins/metabolism , Male , Matrix Metalloproteinase 9/metabolism , Middle Aged , Myocarditis/immunology , Myocytes, Cardiac/physiology , Myosins/immunology , Natriuretic Peptide, Brain/blood , Proto-Oncogene Proteins/metabolism , Rats , Swine , Young Adult
4.
J Nutr Biochem ; 21(8): 749-56, 2010 Aug.
Article in English | MEDLINE | ID: mdl-19615879

ABSTRACT

The micronutrient iron is an essential component that plays a role in many crucial metabolic reactions. The peptide hormone hepcidin is thought to play a central role in iron homeostasis and its expression is induced by iron overloading and inflammation. Recently, hepcidin has been reported to be expressed also in the heart; however, the kinetics of altered hepcidin expression in diseases of the heart remain unknown. In this study, we examined cardiac expression of hepcidin in rat experimental autoimmune myocarditis (EAM), human myocarditis and rat acute myocardial infarction (AMI). In rat EAM and AMI hearts, hepcidin was expressed in cardiomyocytes; ferroportin, which is a cellular iron exporter bound by hepcidin, was also expressed in various cells. Analysis of the time course of the hepcidin to cytochrome oxidase subunit 6a (Cox6a)2 expression ratio showed that it abruptly increased more than 100-fold in hearts in the very early phase of EAM and in infarcted areas 1 day after MI. The hepcidin/Cox6a2 expression ratio correlated significantly with that of interleukin-6/gamma-actin in both EAM and AMI hearts (r=0.781, P<.0001 and r=0.563, P=.0003). In human hearts with histological myocarditis, the ratio was significantly higher than in those without myocarditis (0.0400+/-0.0195 versus 0.0032+/-0.0017, P=.0045). Hepcidin is strongly induced in cardiomyocytes under myocarditis and MI, conditions in which inflammatory cytokine levels increase and may play an important role in iron homeostasis and free radical generation.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Myocardial Infarction/metabolism , Myocarditis/metabolism , Myocardium/metabolism , Adult , Aged , Animals , Base Sequence , DNA Primers , Disease Models, Animal , Female , Hepcidins , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Interleukin-6/metabolism , Male , Middle Aged , Rats , Rats, Inbred Lew , Reverse Transcriptase Polymerase Chain Reaction
5.
Transl Res ; 152(3): 119-27, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18774541

ABSTRACT

Cardiomyocytes with myocarditis compared with the normal state are thought to change the expressions of various genes greatly, some of which may be new biomarkers or new biologic medicinal products. However, until now, little comprehensive analysis has been made of gene-expression changes in cardiomyocytes with myocarditis. In this study, we performed a DNA microarray analysis by using cardiomyocytes from rat experimental autoimmune myocarditis (EAM). On day 0, rats were immunized with porcine cardiac myosin and cardiomyocytes were isolated and purified from EAM hearts and normal hearts by a method that is hardly thought to change gene expressions in cardiomyocytes. RNA from normal cardiomyocytes and cardiomyocytes of EAM on day 18 was analyzed for 7711 gene expressions by DNA microarray. Some gene expressions showed over 10-fold changes. In particular, the regenerated gene (Reg)2/pancreatitis-associated protein (PAP)1 messenger RNA (mRNA) level most markedly increased in the genes, which were clearly expressed in cardiomyocytes rather than in noncardiomyocytes, and it was approximately 2000-fold greater in cardiomyocytes under active myocarditis than normal by real-time reverse transcription polymerase chain reaction analysis. Moreover, we demonstrated that Reg2/PAP1 proteins determined by Western blot analysis and immunohistochemistry and other Reg/PAP family gene expressions were remarkably increased in EAM hearts; in addition, interleukin (IL)-6 expression was significantly related to Reg2/PAP1. It seemed that these data were useful as a reference database of gene-expression changes in cardiomyocytes with myocarditis. The Reg/PAP family, which was found to show dramatically increasing gene expressions by DNA microarray analysis, was suspected to play an important role in myocarditis.


Subject(s)
Gene Expression , Myocarditis/genetics , Myocytes, Cardiac/metabolism , Nervous System Autoimmune Disease, Experimental/genetics , Animals , Antigens, Neoplasm/genetics , Antigens, Neoplasm/metabolism , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Disease Models, Animal , Gene Expression Profiling , Lectins, C-Type/genetics , Lectins, C-Type/metabolism , Myocarditis/metabolism , Myocarditis/pathology , Myocytes, Cardiac/pathology , Nervous System Autoimmune Disease, Experimental/metabolism , Nervous System Autoimmune Disease, Experimental/pathology , Oligonucleotide Array Sequence Analysis , Pancreatitis-Associated Proteins , RNA, Messenger/metabolism , Rats , Rats, Inbred Lew
6.
J Immunol ; 177(6): 3635-43, 2006 Sep 15.
Article in English | MEDLINE | ID: mdl-16951323

ABSTRACT

IL-22 is one of several cytokines with limited homology to IL-10. However, the biological activities of IL-22 are mostly unknown. The purpose of this study was to evaluate the effect of IL-22 on rat experimental autoimmune myocarditis (EAM) and elucidate an aspect of the biological activities of IL-22. Rats were immunized on day 0; IL-22-Ig-treated rats were injected with pCAGGS-IL-22-Ig and control rats with pCAGGS-Ig using hydrodynamics-based gene delivery on day 1 or day 6. IL-22-Ig gene therapy administered on day 1 or day 6 after immunization was effective in controlling EAM as monitored by the heart weight to body weight ratio, and the myocarditis area in rats was sacrificed on day 17. Examination of the expression of IL-22-related genes in purified cells from EAM hearts suggested that IL-22-Ig acting target cells were noncardiomyocytic (NC) noninflammatory cells such as fibroblasts, smooth muscle cells, and endothelial cells. Therefore, we examined the effect of rIL-22 or serum containing IL-22-Ig on the expression of immune-relevant genes in IL-1-stimulated NC cells cultured from EAM hearts. Results showed that the expression of immunologic molecules (PGE synthase, cyclooxygenase-2, MIP-2, MCP-1, IL-6, and cytokine-induced neutrophil chemoattractant-2) in IL-1-stimulated NC cells was significantly decreased by rIL-22 or serum containing IL-22-Ig. EAM was suppressed by hydrodynamics-based delivery of plasmid DNA encoding IL-22-Ig, and the reason for this effectiveness may be that IL-22 suppressed gene expression of PG synthases, IL-6, and chemokines in activated NC noninflammatory cells.


Subject(s)
Autoimmune Diseases/genetics , Autoimmune Diseases/therapy , Drug Delivery Systems , Genetic Therapy , Interleukins/genetics , Myocarditis/genetics , Myocarditis/therapy , Recombinant Fusion Proteins/genetics , Animals , Autoimmune Diseases/pathology , Cells, Cultured , DNA/administration & dosage , DNA/therapeutic use , Gene Fusion , Immunoglobulins/administration & dosage , Immunoglobulins/genetics , Interleukins/administration & dosage , Leukocyte Count , Male , Myocarditis/pathology , Plasmids/administration & dosage , Rats , Rats, Inbred Lew , Recombinant Fusion Proteins/administration & dosage , Interleukin-22
7.
J Card Fail ; 11(7): 557-64, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16198253

ABSTRACT

BACKGROUND: Rat experimental autoimmune myocarditis (EAM) is a T cell-mediated disease that resembled the giant cell myocarditis seen in humans. Soluble CTLA4 improves some autoimmune diseases by blocking costimulatory signals on T cell. We investigated the effect of hydrodynamics-based naked plasmid DNA encoding CTLA4-immunoglobulin (Ig) gene delivery. METHODS AND RESULTS: Lewis rats were immunized with cardiac myosin and treated with hydrodynamic-based transfection, namely a rapid tail vein injection of a large volume of pCAGGS encoding CTLA4-Ig chimera solution on Day 0. The vector-derived CTLA4-Ig mRNA expressions were mainly detected in the liver and plasma CTLA4-Ig protein levels were maintained at about 2 mug/mL during the experiment period. On Day 17, the ratio of heart to body weight, the amount of mRNA of atrial natriuretic peptide, and the inflammatory areas in CTLA4 group were significantly lower than in the control group treated with empty plasmid. Maximum rate of intraventricular pressure rise and decline (dP/dT), minimum dP/dT, left ventricular end-diastolic pressure, and central venous pressure improved significantly after treatment with CTLA4-Ig. On Day 14, expressions of IL-2 in popliteal lymph nodes in the CTLA4-Ig group were significantly lower than in the control group. CONCLUSION: Hydrodynamics-based transfection of plasmid encoding CTLA4-Ig chimera dramatically prevented EAM.


Subject(s)
Autoimmune Diseases/therapy , Genetic Therapy/methods , Immunoconjugates/genetics , Myocarditis/therapy , Abatacept , Animals , Atrial Natriuretic Factor/metabolism , Autoimmune Diseases/genetics , Autoimmune Diseases/metabolism , Disease Models, Animal , Immunoconjugates/metabolism , Interleukin-2/metabolism , Lymph Nodes/metabolism , Male , Myocarditis/genetics , Myocarditis/metabolism , Plasmids/genetics , Popliteal Artery/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred Lew , Time Factors , Transfection/methods , Ventricular Pressure/physiology
8.
Cardiovasc Res ; 68(2): 278-88, 2005 Nov 01.
Article in English | MEDLINE | ID: mdl-16018993

ABSTRACT

BACKGROUND: In a heart with myocarditis, there are cardiomyocytes, inflammatory cells, and non-inflammatory interstitial cells. Immunological molecules are thought to influence not only inflammatory cells but also cardiac function and remodeling. Whatever their origin, the cells they target and the intercellular crosstalk they mediate remain unclear. Here, we examined native gene expression of immunological molecules in normal and rat experimental autoimmune myocarditis (EAM) 18 and 90 days after immunization, using real time RT-PCR in cardiomyocytes, CD11b(+) cells, alphabetaT cells and non-cardiomyocytic non-inflammatory (NCNI) cells. METHODS AND RESULTS: Cells were isolated by collagenase perfusion on a Langendorff apparatus and purified by passing through a stainless-steel sieve followed by magnetic bead column separation using appropriate monoclonal antibodies. Most immunological molecules were expressed in inflammatory cells. However, some were expressed in NCNI cells or cardiomyocytes. Interestingly, most of interleukin (IL)-10, monocyte chemoattractant protein (MCP)-1, or tumor necrosis factor (TNF)-alpha receptor were found in NCNI cells and most of fractalkine were found in NCNI cells and cardiomyocytes. Moreover, TNF-alpha significantly upregulated fractalkine and MCP-1 mRNA in cultivated cells from EAM hearts. CONCLUSION: In the rat experimental myocarditis heart, inflammatory cells express many immunological molecules. Some of them are thought to influence NCNI cells or cardiomyocytes directly via receptors on these cell types. It is further suggested that fractalkine, IL-10, and MCP-1 expressed in NCNI cells or cardiomyocytes regulate inflammatory cells.


Subject(s)
Autoimmune Diseases/immunology , Chemokines/analysis , Myocarditis/immunology , Myocytes, Cardiac/immunology , T-Lymphocytes/immunology , Animals , Chemokine CCL2/analysis , Chemokine CX3CL1 , Chemokines, CX3C/analysis , Fibroblasts/immunology , Flow Cytometry , Hyaluronan Receptors/analysis , Immunohistochemistry/methods , Interleukin-10/analysis , Membrane Proteins/analysis , Muscle, Smooth, Vascular/immunology , Myocardium/immunology , Myocardium/pathology , Osteopontin , Rats , Rats, Inbred Lew , Receptors, Interferon/analysis , Receptors, Tumor Necrosis Factor/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sialoglycoproteins/analysis , Interferon gamma Receptor
9.
Eur J Immunol ; 35(6): 1995-2005, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15902684

ABSTRACT

Interleukin (IL)-13 is a pleiotropic cytokine secreted by activated Th2 T lymphocytes. Th1 cytokines are assumed to exacerbate and Th2 cytokines to ameliorate rat experimental autoimmune myocarditis (EAM). Here, we examined the effect of IL-13 on EAM, using a hydrodynamics-based delivery of an IL-13-Ig fusion gene, as well as the possible mechanism of its effect. Rats were immunized on day 0, and IL-13-Ig-treated rats were injected with pCAGGS-IL-13-Ig, and control rats with pCAGGS-Ig, on day 1 or 7. On day 17, the IL-13-Ig gene therapy was effective in controlling EAM as monitored by a decreased heart weight/body weight ratio, by reduced myocarditis and by reduced atrial natriuretic peptide mRNA in the heart, as a heart failure marker. On the basis of IL-13 receptor mRNA expression in separated cells from EAM hearts, we proposed that IL-13-Ig target cells were CD11b(+) cells and non-cardiomyocytic noninflammatory (NCNI) cells, such as fibroblasts, smooth muscle or endothelial cells. IL-13-Ig inhibited expression of the genes for prostaglandin E synthase, cyclooxygenase-2, inducible nitric oxide synthase, IL-1beta and TNF-alpha in cultivated cells from EAM hearts, while it enhanced expression of the IL-1 receptor antagonist gene. We conclude that IL-13-Ig ameliorates EAM and suppose that its effectiveness may be due to the influence on these immunologic molecules in CD11b(+) and NCNI cells.


Subject(s)
Autoimmune Diseases/therapy , Genetic Therapy , Interleukin-13/genetics , Myocarditis/therapy , Recombinant Fusion Proteins/genetics , Animals , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , CD11b Antigen/analysis , Cells, Cultured , Interleukin-13/blood , Interleukin-13 Receptor alpha1 Subunit , Myocarditis/immunology , Myocarditis/pathology , Plasmids , RNA, Messenger/analysis , Rats , Rats, Inbred Lew , Receptors, Interleukin/genetics , Receptors, Interleukin-13 , Receptors, Interleukin-4/genetics
10.
Circ J ; 69(5): 521-5, 2005 May.
Article in English | MEDLINE | ID: mdl-15849436

ABSTRACT

BACKGROUND: Elevated lipoprotein(a) (Lp(a)) concentrations are reported to impair endothelium-dependent vasodilatation of the epicardial coronary artery. However, the effects on vasomotor abnormalities in coronary spastic angina (CSA) have not been thoroughly investigated. METHODS AND RESULTS: In the present study 80 sites of spasm (spastic sites) without significant organic stenosis (% diameter stenosis <50%) were assessed in 80 patients with CSA diagnosed by intracoronary ergonovine (EM) test. Spastic sites were divided into 2 groups: Group 1 included 30 sites provoked by the full dose (=50 microg) of EM, and Group 2 included 50 sites provoked with less than 50 microg (34.7+/-8.2 microg). Control subjects (n=22) did not show coronary spasm with the EM test. Serum Lp(a) concentrations were measured in all patients. Group 2 had a significantly greater basal coronary artery tone in the spastic sites than Group 1 (p<0.001). Lp(a) level in Group 2 was significantly higher compared with both the control group and Group 1 (p<0.05 by analysis of variance). Multivariate analysis confirmed that only serum Lp(a) concentration was associated with low-dose EM spasm provocation. CONCLUSIONS: Serum Lp(a) concentration could be a marker for high disease activity in CSA.


Subject(s)
Angina Pectoris/blood , Coronary Vasospasm/blood , Lipoprotein(a)/blood , Vasodilation , Adult , Aged , Angina Pectoris/physiopathology , Biomarkers/blood , Coronary Vasospasm/physiopathology , Coronary Vessels/physiopathology , Female , Humans , Male , Middle Aged
11.
Circulation ; 111(13): 1593-600, 2005 Apr 05.
Article in English | MEDLINE | ID: mdl-15795329

ABSTRACT

BACKGROUND: Interleukin-1 (IL-1) is a powerful and important cytokine in myocarditis. The purpose of this study was to evaluate the effect and possible mechanism of hydrodynamics-based delivery of the IL-1 receptor antagonist (IL-1RA)-immunoglobulin (Ig) gene for treatment of rat experimental autoimmune myocarditis (EAM). METHODS AND RESULTS: On the day after immunization, rats were transfected with either pCAGGS encoding IL-1RA-Ig or pCAGGS encoding Ig alone. On day 17, IL-1RA-Ig gene therapy was effective in controlling EAM, as monitored by a decreased ratio of heart weight to body weight, reduced myocarditis areas, reduced gene expression of atrial natriuretic peptide in hearts, and improved cardiac function in echocardiographic and hemodynamic parameters. Examination of the expression of IL-1-related genes in purified cells from EAM hearts suggested that ectopic IL-1RA-Ig-acting target cells were alphabetaT cells and noncardiomyocytic noninflammatory cells such as fibroblasts, smooth muscle cells, and endothelial cells. Therefore, we examined the effect of serum containing IL-1RA-Ig on the expression of immune-relevant genes within noncardiomyocytic cells cultured from EAM hearts or concanavalin A-stimulated lymphocytes derived from lymph nodes in EAM-affected rats. The expression of immunologic molecules (prostaglandin E synthase, cyclooxygenase-2, and IL-1beta) in cultivated noncardiomyocytic cells and Th1 cytokines (IL-2 and IFN-gamma) in lymphocytes was significantly decreased by the serum containing IL-1RA-Ig. CONCLUSIONS: EAM was suppressed by hydrodynamics-based delivery of plasmid DNA encoding IL-1RA-Ig. In addition, IL-1RA-Ig suppressed gene expression of prostaglandin synthases and IL-1 in noncardiomyocytic cells and Th1 cytokines in lymphocytes.


Subject(s)
Autoimmune Diseases/therapy , Genetic Therapy/methods , Immunoglobulins/administration & dosage , Myocarditis/therapy , Plasmids/administration & dosage , Sialoglycoproteins/administration & dosage , Animals , Cells/drug effects , Cells/metabolism , Cytokines/genetics , Disease Models, Animal , Gene Expression Regulation/immunology , Immune System/drug effects , Immunoglobulins/genetics , Immunoglobulins/therapeutic use , Interleukin 1 Receptor Antagonist Protein , Lymphocytes/drug effects , Lymphocytes/metabolism , Male , Plasmids/therapeutic use , Prostaglandin-Endoperoxide Synthases/genetics , Rats , Rats, Inbred Lew , Sialoglycoproteins/genetics , Sialoglycoproteins/therapeutic use
12.
Tohoku J Exp Med ; 202(3): 155-61, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15065641

ABSTRACT

Gene therapy is expected to lead to new and useful methods to treat diseases. The development of assays to quantitate gene-therapy-derived proteins circulating in blood will be essential to investigate the effects and side effects of the introduced proteins. The purpose of this study is to evaluate whether a protein circulating at trace concentrations in blood can be measured by tagging a peptide corresponding to glucagon residues 19-29 onto its C-terminal end. We constructed plasmids encoding chimeric proteins and transferred them into rats by hydrodynamics-based delivery. When plasmids encoding human IL8-glucagon 19-29 chimeric protein were injected into rats to evaluate the accuracy of this method, there was a high correlation between chimeric proteins measured by an enzyme-linked immunosorbent assay for human IL8 and one by a radioimmunoassay for glucagon. Furthermore, when plasmids coding rat IFN gamma receptor IgG-Fc glucagon 19-29 chimeric protein were injected to evaluate the time course of chimeric proteins in blood plasma, we could calculate the concentrations in blood from 10 microl plasma samples using glucagon 19-29 tag as follows: 2815+/-2318 ng/ml after 4 hours (mean+/-s.D.), 6061+/-2789 ng/ml after 8 hours, 5752+/-2270 ng/ml after 12 hours, 2870+/-1062 ng/ml after one day, 1440+/-334 ng/ml after three days, 1120+/-433 ng/ml after seven days, and 281+/-162 ng/ml after 16 days. Blood sugar levels which might have been increased by glucagon did not increase even at peak chime- ric protein concentrations. These results demonstrate a useful and convenient method to assay gene therapy products circulating in blood using a glucagon 19-29 tagging vector.


Subject(s)
Gene Transfer Techniques , Immunoassay/methods , Plasmids/genetics , Proteins/chemistry , Proteins/metabolism , Animals , Blood Glucose/metabolism , Genetic Therapy/methods , Glucagon/genetics , Glucagon/metabolism , Humans , Interleukin-8/genetics , Interleukin-8/metabolism , Male , Peptide Fragments/genetics , Peptide Fragments/metabolism , Rats , Receptors, Interferon/genetics , Receptors, Interferon/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Interferon gamma Receptor
13.
Virchows Arch ; 444(3): 283-92, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14624362

ABSTRACT

Coxsackievirus B is the most common cause of viral myocarditis and is particularly virulent in neonates and children. Adenovirus is also a leading cause of the disease. The determinant of tropism for both viruses is considered to be the expression of coxsackievirus and adenovirus receptor (CAR) in target organs. However, developmental change and physiological localization of CAR in the heart are unknown. We examined expression levels of CAR in rat hearts by quantitative real-time polymerase chain reaction and Western blot analysis and found that CAR decreased gradually during postnatal development, although CAR was detectable, even in adults. Immunohistochemistry revealed CAR on the whole surface of cardiomyocytes in immature rat hearts. In contrast, CAR was detected predominantly on intercalated disks in the adult heart and was accumulated especially at the contact point between the cultured cardiomyocytes, even though they were prepared from the neonatal rat heart. In conclusion, CAR was expressed abundantly on the whole surface of cardiomyocytes in immature rat hearts. Both the expression level and the localization of CAR are possible determinants of the susceptibility to viral myocarditis of neonates and children.


Subject(s)
Animals, Newborn , Heart/growth & development , Heart/virology , Myocytes, Cardiac/chemistry , Receptors, Virus/analysis , Animals , Cells, Cultured , Connexin 43/analysis , Coxsackie and Adenovirus Receptor-Like Membrane Protein , Fluorescent Antibody Technique , Immunohistochemistry , Myocardium/chemistry , Myocytes, Cardiac/virology , RNA, Messenger/analysis , Rats , Rats, Inbred Lew , Receptors, Virus/genetics , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...